Different Outcomes of Anti-VEGF Treatment for Neovascular AMD according to Neovascular Sutypes and Baseline Features: 2-Year Real-Life Clinical Outcomes

Table 2

Correlation analysis. The following abbreviations are used: MNV: macular neovascularization; BCVA: best-corrected visual acuity; CMT central macular thickness.

Correlation analysis
		Tau-Kendall value	value
MNV Type	BCVA 1 y	0.349	<0.01
	BCVA 2 y	0.329	<0.01
BCVA baseline	BCVA 1 y	0.55	<0.01
	BCVA 2 y	0.55	<0.01
	CMT baseline	0.259	<0.01
BCVA 1 y	BCVA 2 y	0.709	<0.01
CMT baseline	CMT 1 y	0.254	<0.01
CMT 1 y	CMT 2 y	0.317	<0.01